V-Square Quantitative Management’s Vertex Pharmaceuticals VRTX Stock Holding History

V-Square Quantitative Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75M	Sell	5,531 -175	-3%	-$77.6K	0.26%	57
2026 Q1	$2.55M	Buy	5,706 +82	+1%	+$38.2K	0.27%	56
2025 Q4	$2.55M	Buy	+5,624	New	+$2.42M	0.27%	55
2025 Q3	–	Sell	-5,970	Closed	-$2.66M	–	580
2025 Q2	$2.66M	Buy	5,970 +1,875	+46%	+$864K	0.36%	48
2025 Q1	$1.99M	Sell	4,095 -91	-2%	-$42.4K	0.29%	65
2024 Q4	$1.69M	Buy	4,186 +489	+13%	+$227K	0.24%	74
2024 Q3	$1.72M	Buy	3,697 +208	+6%	+$99.9K	0.25%	73
2024 Q2	$1.64M	Buy	3,489 +49	+1%	+$21.3K	0.27%	64
2024 Q1	$1.44M	Buy	3,440 +1,052	+44%	+$445K	0.2%	76
2023 Q4	$972K	Buy	2,388 +1,214	+103%	+$448K	0.17%	84
2023 Q3	$408K	Buy	1,174 +557	+90%	+$195K	0.18%	118
2023 Q2	$217K	Sell	617 -1,505	-71%	-$507K	0.16%	127
2023 Q1	$669K	Buy	+2,122	New	+$636K	0.62%	40

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

V-Square Quantitative Management's VRTX Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q2 2026, selling an estimated $77.6K and leaving 5,531 shares worth $2.75M. The position accounts for 0.26% of the portfolio, ranked #57.

V-Square Quantitative Management first reported a position in VRTX in Q1 2023 and has held it in 13 quarters since. 662 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

V-Square Quantitative Management held 5,531 shares of Vertex Pharmaceuticals worth $2.75M as of Q2 2026.
V-Square Quantitative Management sold 175 Vertex Pharmaceuticals shares in Q2 2026, an estimated $77.6K.
Vertex Pharmaceuticals made up 0.26% of V-Square Quantitative Management's portfolio in Q2 2026, its #57 holding.
V-Square Quantitative Management first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
662 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.